Nintedanib-induced lichenoid drug eruption: a case report
Mahesh Mathur, Sumit Paudel, Sambidha Karki, Nabita Bhattarai, Sharad Shrestha, Sandhya Regmi · 2026
Read Nintedanib-induced lichenoid drug eruption: a case report by Mahesh Mathur, Sumit Paudel, Sambidha Karki, Nabita Bhattarai, Sharad Shrestha, Sandhya Regmi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13425075.txt.
Description
Mahesh Mathur and co-authors report a 2026 case of a skin eruption caused by the drug nintedanib, an association they say has not been described before. The eruption is lichenoid, meaning it mimics the skin disease lichen planus but with a wider mix of forms, including scaly and eczema like patches. It arises as a delayed allergy type reaction to a drug.
Many drug classes are known triggers, from blood pressure and malaria drugs to beta blockers. Nintedanib works inside cells by blocking growth factor receptors that drive scarring and vessel growth, and it is used for lung scarring diseases. A new skin reaction on a widely used drug matters for clinics: spotting the drug as the cause is the first step to settling the skin. The case adds nintedanib to the trigger list for this eruption.
Catalog record
| CREATOR | Mahesh Mathur, Sumit Paudel, Sambidha Karki, Nabita Bhattarai, Sharad Shrestha, Sandhya Regmi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |